Kimberly-Clark seeks to enhance global business plans with executive changes
DALLAS — Kimberly-Clark announced the transition of two executives to new roles at the company.
The company said Kimberly-Clark Professional president Christian Brickman has been elected to serve as president Kimberly-Clark International. The current president of the company’s international division, Bob Black, is leaving the company to pursue other opportunities. Replacing Brickman in his current role is Elaine Stock, who currently serves as Kimberly-Clark’s SVP and chief strategy officer.
The changes, which are designed to further enhance the company’s focus to deliver its global business plan commitments and drive global expansion, are effective May 1. Both Brickman and Stock will continue to report to company chairman and CEO Thomas Falk.
"We have a great team in place to drive our business plan strategies across the globe," Falk said. "Chris and Elane are strong leaders with excellent track records. Chris brings tremendous experience and success into his K-C International role and will continue to drive the expansion of our international business. Elane’s general management and strategy experience make her the ideal successor to expand on our Kimberly-Clark Professional business aspiration to create exceptional workplaces."
Optics Lab announces consumer ad campaign in time for allergy season
EL MONTE, Calif. — Optics Lab has kicked off a new consumer campaign in support of its OcuFresh Eye Wash product, the company announced Tuesday.
The product, which helps flush out such eye irritants as pollen, dust and smoke, will be featured across the "Mommy Blog" circuit and in such print publications as Prevention, Redbook and Allergies Today.
The company also is circulating a 15-second spot featured on YouTube here.
Study: Vitamin E supplementation has no impact on heart disease in women
DALLAS — Taking vitamin E supplements does not increase or decrease heart failure risk among women, according to a study in Circulation: Heart Failure, an American Heart Association journal, released Tuesday.
According to researchers, the study is one of the first to investigate the effectiveness of vitamin E to prevent the development of heart failure. Researchers studied nearly 40,000 women in the Women’s Health Study who took 600 international units of vitamin E or placebo every other day. The women were ages 45 years or older and healthy at the study’s start. Researchers followed them for an average 10.2 years to determine if taking the supplement affected heart failure risk. Investigators recorded 220 heart failure cases.
Overall, researchers found no impact from vitamin E supplementation. They did, however, observe a 41% decrease in the risk of developing a type of heart failure in which the heart retains its normal pumping function. This finding only is an observation and topic for future research, according to Claudia Chae, lead researcher in the cardiology division at Massachusetts General Hospital in Boston.
Dietary supplement advocates historically have cautioned consumers regarding the results of supplement usage studied as part of a drug-like trial because of the difficulty in isolating supplement intake across test subjects. Beyond supplementation, vitamin E levels in test subjects can fluctuate based on their consumption of vegetable oils, nuts, seeds, green vegetables and fortified cereals, or other foods that have significant amounts of vitamin E.
"Vitamins work synergistically and … drug-like trials of nutrients, when used in isolation from other nutrients, may not be the most appropriate way to study them," said Duffy MacKay, VP scientific and regulatory affairs for the Council for Responsible Nutrition, late last year regarding a vitamin E usage study in men. "For questions about vitamin E, consumers should talk with their physician, nurse practitioner, pharmacist or other healthcare practitioner."